" class="no-js "lang="en-US"> Étienne de Villers-Sidani - Medtech Alert
Sunday, September 21, 2025

Breaking News

Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Astellas and Cullgen Enter into Strategic Collaboration and Option Agreement to Advance Innovative Targeted Protein Degraders Auxilius Pharma Raises Seed Funding of $1 Million and Commences its Clinical Program Captivate Bio and EverCell Bio partner on Human Cell Modeling Services for Cell and Gene Therapy Markets Applied StemCell Partners with CIRM to Provide Clinical-Grade iPSCs and Access to Its Proprietary Gene Editing Technologies Alentis Therapeutics Receives IND Clearance from FDA for ALE.C04 for the Treatment of CLDN1+ Tumors
Étienne de Villers-Sidani

Étienne de Villers-Sidani

About Étienne de Villers-Sidani

Dr. de Villers-Sidani is a cognitive neurologist who completed his post-doctoral studies at the UCSF Keck Foundation Center for Integrative Neurosciences. He is currently an Associate Professor of Neurology and Neurosurgery at McGill University and is an attending neurologist and Director of the Neuroplasticity and Sensory Biomarking Laboratory of the Montreal Neuro.

Related Story

Artificial Intelligence

 ETNA™ Device From the Leading Digital Health & AI Company Innodem Neurosciences Receives FDA"Breakthrough" Designation for Multiple Sclerosis | Pharmtech Focus

ETNA™ Device From the Leading Digital Health & AI Company Innodem Neurosciences Receives FDA"Breakthrough" Designation for Multiple Sclerosis

May 31 2022

Innodem Neurosciences, a leading provider of innovation and technology for the convergence of neurosciences, digital […]